-

Agilent Presents Thought Leader Award to Professor Chris Elliott

Renowned Queen’s University Belfast scientist recognized for his research in food authenticity

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Chris Elliott has received an Agilent Thought Leader Award. Dr. Elliott is Professor of Food Safety in the School of Biological Sciences and founder of the Institute for Global Food Security (IGFS) at Queen’s University Belfast in Northern Ireland. The award recognizes his contributions to the field of food authenticity and the development of novel approaches to the detection of food fraud.

Professor Elliott is a globally recognized expert on international food supply chains and the implications for food quality, authenticity, integrity, and safety. The award includes an Agilent 1290 Infinity II LC System coupled with a 6546 LC-Q/TOF, a 7850 ICP-MS instrument, and sample preparation and analysis consumables. The award will support Professor Elliott and his team in developing innovative analytical approaches that will help solve complex food authenticity challenges, focusing on making complex test methods more routine and easier to use.

“I’m deeply honored to be the recipient of such a large and prestigious award,” stated Professor Elliott. “The partnership between our institute and Agilent to provide cutting-edge scientific tools to help combat the growing menace of food fraud globally will go from strength to strength. Together we will help support the development of the global food supply system based on the core principles of integrity.”

“Providing this award to Professor Elliott is an honor as Agilent is committed to helping ensure that the world’s global food supply is safe,” stated Sudharshana Seshadri, vice president of Agilent's Mass Spectrometry Division and executive sponsor of the award. “The development of new test methods that are fast and easier to use will enable much broader adoption and implementation of food authenticity testing in more labs.”

Food fraud is on the rise, impacting a vast array of food products and causing significant concerns for the food industry, regulators, and consumers. Agilent’s advanced mass spectrometry and spectroscopy technologies can effectively analyze food product classification, ascertain contaminant and degradation levels, and help confirm points of origin and production.

The Agilent Thought Leader Award program promotes fundamental scientific advances by contributing financial support, products, and expertise to the research of influential thought leaders in the life sciences, diagnostics, and chemical analysis space. To learn more, visit the Agilent Thought Leader Award web site.

About Agilent Technologies

Agilent is a leader in life sciences, diagnostics, and applied chemical markets, delivering innovative technology solutions that provide trusted answers to researchers’ most challenging scientific questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Naomi Goumillout
Agilent Technologies, Inc.
+1.781.266.2819
naomi.goumillout@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Naomi Goumillout
Agilent Technologies, Inc.
+1.781.266.2819
naomi.goumillout@agilent.com

More News From Agilent Technologies Inc.

Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.The new SEC and PLRP-S columns support critical analytical workflows across a range of biotherapeutic modalities, including peptides, proteins, oligonucleotides...

Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA eSight instrument with AI-driven cell imaging analysis, enabling researchers to...

Agilent Completes Acquisition of Biocare Medical

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group.“We are pleased to complete our acquisition of Biocare, which represents a natural and st...
Back to Newsroom